United States - English - NLM (National Library of Medicine)

reviresco co., ltd. - tranexamic acid (unii: 6t84r30kc1) (tranexamic acid - unii:6t84r30kc1), adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567) - purpose: anti wrinkle uses: for anti-wrinkle

United States - English - NLM (National Library of Medicine)

shantou youjia e-commerce co., ltd. - arbutin (unii: c5ina23hxf) (arbutin - unii:c5ina23hxf), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), glycerin (unii: pdc6a3c0ox) (glycerin - unii:pdc6a3c0ox), hyaluronic acid (unii: s270n0trqy) (hyaluronic acid - unii:s270n0trqy), tranexamic acid (unii: 6t84r30kc1) (tranexamic acid - unii:6t84r30kc1) -

New Zealand - English - Medsafe (Medicines Safety Authority)

medsurge pharma limited - tranexamic acid 100 mg/ml;   - solution for injection - 500 mg/5ml - active: tranexamic acid 100 mg/ml   excipient: hydrochloric acid sodium hydroxide water for injection - haemorrhage or risk of haemorrhage in increased fibrinolysis or fibrinogenolysis. local fibrinolysis may occur in the following conditions: - prostatectomy and bladder surgery - menorrhagia - epistaxis - conisation of the cervix - management of dental extraction in patients with coagulopathies - ulcerative colitis - haematuria (tranexamic acid therapy is not indicated in haematuria caused by diseases of the renal parenchyma (also see precautions). - gastrointestinal haemorrhage.

New Zealand - English - Medsafe (Medicines Safety Authority)

boucher & muir (nz) ltd t/a mercury pharma (nz) - tranexamic acid 500mg - film coated tablet - 500 mg - active: tranexamic acid 500mg excipient: basic butylated methacrylate copolymer colloidal silicon dioxide croscarmellose sodium isopropyl alcohol macrogol 8000 magnesium stearate   microcrystalline cellulose povidone purified talc   purified water titanium dioxide vanillin - haemorrhage or risk of haemorrhage in increased fibrinolysis or fibrinogenolysis. local fibrinolysis may occur in the following conditions: -prostatectomy and bladder surgery -menorrhagia -epistaxis -conisation of the cervix - management of dental extraction in patients with coagulopathies - ulcerative colitis - haematuria (tranexamic acid therapy is not indicated in haematuria caused by diseases of the renal parenchyma) -gastrointestinal haemorrhage general fibrinolysis as in prostatic and pancreatic cancer; after thoracic and other major surgery: - in obstetrical complications such as abruptio placentae and post-partum haemorrhage - in leukaemia and liver diseases and in connection with thrombolytic therapy with streptokinase hereditary angioneurotic oedema. for the reduction of peri– and post-operative blood loss and the need for blood transfusion in adult patients undergoing cardiac surgery or total knee arthroplasty or total hip arthroplasty. for the reduction of peri- and post-operative blood loss and the need for blood transfusion in paediatric patients undergoing cardiac surgery.

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - tranexamic acid ph. eur. - solution for injection/infusion - 100 milligram(s)/millilitre - tranexamic acid

Malta - English - Medicines Authority

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - tranexamic acid - film-coated tablet - tranexamic acid 500 mg - antihemorrhagics

Malta - English - Medicines Authority

ibigen s.r.l via fossignano, 2, 04011 aprilia (lt), italy - tranexamic acid - solution for injection/infusion - tranexamic acid 100 mg/ml - antihemorrhagics

Malta - English - Medicines Authority

ibigen s.r.l via fossignano, 2, 04011 aprilia (lt), italy - tranexamic acid - solution for injection/infusion - tranexamic acid 100 mg/ml - antihemorrhagics

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - tranexamic acid - solution for injection - 100 mg/ml - tranexamic acid

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sovereign medical ltd - tranexamic acid - oral tablet - 500mg